Satomic offers an AI‑powered platform that speeds the transition from chemical concept to viable molecule by enabling rapid navigation of chemical space. The service provides tools for virtual screening, property prediction, and synthesis planning, allowing researchers to explore and optimize candidate compounds more efficiently and bring new molecules to market faster.
Funding
Funding not disclosed
Founders
Product
Problem
Researchers in drug discovery and materials science often face lengthy, iterative cycles when moving from a conceptual idea to a viable chemical compound, due to the difficulty of efficiently exploring vast chemical space.
Solution
Satomic provides a cloud‑based platform that accelerates the transition from concept to molecule by integrating advanced computational tools for rapid navigation of chemical space. Users input target properties or design criteria, and the system generates and ranks candidate structures using AI‑driven synthesis prediction and property estimation. The platform streamlines hypothesis testing, allowing scientists to identify promising compounds in fewer iterations and reduce overall development time. Results are delivered through an interactive interface that supports export of molecular data for downstream experimental validation.
Target Audience
Primary users are medicinal chemists, materials scientists, and R&D teams in pharmaceutical and advanced materials companies seeking faster compound ideation and optimization.
Features
- AI‑powered generative models that propose novel chemical structures aligned with user‑defined objectives
- Integrated property prediction engines for activity, toxicity, and physicochemical attributes
- Automated synthetic feasibility assessment to prioritize synthetically accessible candidates
- Interactive dashboard for visualizing chemical space exploration and ranking results
- Export tools for common cheminformatics formats (e.g., SMILES, SDF) to facilitate laboratory workflows